A detailed history of Linden Thomas Advisory Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 2,829 shares of NVO stock, worth $316,678. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,829
Previous 2,263 25.01%
Holding current value
$316,678
Previous $323 Million 4.28%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$119.07 - $145.42 $67,393 - $82,307
566 Added 25.01%
2,829 $337 Million
Q2 2024

Jul 10, 2024

BUY
$122.71 - $146.91 $44,175 - $52,887
360 Added 18.92%
2,263 $323 Million
Q1 2024

Apr 29, 2024

SELL
$102.11 - $135.92 $16,950 - $22,562
-166 Reduced 8.02%
1,903 $244 Million
Q4 2023

Feb 01, 2024

BUY
$87.78 - $105.45 $181,616 - $218,176
2,069 New
2,069 $214 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.